Sertraline, a selective serotonin reuptake inhibitor, unmasking carcinoid syndrome

American Journal of Gastroenterology

Volumn 92, Issue 8, 1997, Pages 1387-1388

  Noyer, Charles M ^a  

^a Jacob Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

ACROCYANOSIS; ADULT; ARTICLE; CARCINOID SYNDROME; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DIAPHORESIS; DIARRHEA; DOSE RESPONSE; ENZYME INHIBITION; FEMALE; HUMAN; HYPOTENSION; LIVEDO RETICULARIS; PRIORITY JOURNAL; TACHYCARDIA;

1-NAPHTHYLAMINE; CARCINOID TUMOR; DEPRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0030877302     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Bodner RA, Lynch T, Lewis L, et al. Serotonin syndrome. Neurology 1995;45:219-23.
2. Maton PN. The carcinoid syndrome. JAMA 1988;260:1602-5.
3. Vinik AI, McLeod MK, Fig LM, et al. Clinical features, diagnosis, and localization of carcinoid tumors and their manacement. Gastroenterol Clin N Am 1989:18:865-96.
4. Swain CP, Tavill AS, Neale G. Studies of tryptophan and albumin metabolism in a patient with carcinoid syndrome, pellagra, and hypoproteinemia. Gastroenterology 1976:71:484-9.